Loading

Update on NMOSD & MOGAD - ECF MEETING in Sao Paulo

  • Por Bctrims em 16 de Dezembro de 2024

Update on NMOSD & MOGAD - ECF MEETING in Sao Paulo

The "Update on NMOSD & MOGAD" Meeting, that will be held in São Paulo, Brazil on the 7th and 8th of February 2025!
This premier event will bring together top experts, researchers, and healthcare professionals to share the latest insights and advancements in Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).
The complete programme is now available, featuring a diverse array of sessions designed to provide you with practical insights and new perspectives.
For the international participants, a digital option is available, allowing you to join and engage from anywhere.

What to Expect:
?? Cutting-edge research presentations.
?? Breakthroughs in diagnosis, treatment, and management.
?? Opportunities to engage with international leaders and peers in the field.

REGISTRATIONS:

REGISTER FOR THE IN-PERSON METING IN BRAZIL: link

REGISTER NOW FOR THE ONLINE MEETING: link

Abstract submissions are open
We invite researchers and professionals to submit their abstracts and contribute to the "Update on NMOSD & MOGAD" Meeting. This is a unique opportunity to share your work with a global audience and gain recognition for your research. Accepted abstracts will be featured in our digital poster exhibition, and selected top submissions will have the chance to present their findings during oral communication sessions and compete for the Young Investigators Award.

For inquiries or assistance with registration, please contact secretariat@charcot-ms.org .
Follow ECF for updates on Linked In

Looking forward to welcoming you to this exciting congress!
This meeting is organised by the European Charcot Foundation and endorsed by BCTRIMS and ABNO.
 

Deixe seu Comentário

Permitir Cookies

Nós usamos cookies e outras tecnologias semelhantes para melhorar a sua experiência em nossos serviços, personalizar publicidade e recomendar conteúdo de seu interesse. Ao utilizar nossos serviços, você concorda com tal monitoramento. Veja aqui a nossa política de privacidade.